Search research articles
Contact Us
Filters
Showing results (201-210 of 265) with videos related to
Page
of 27
Sort By:
Cancers
|
January 22, 2021
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives
Michela Roberto, Antonio Astone, Andrea Botticelli, et al.
Therapeutic Advances in Medical Oncology
|
March 20, 2023
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
Giovanna Garufi, Luisa Carbognin, Isabella Sperduti, et al.
La Radiologia Medica
|
March 21, 2025
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria
Charlotte Trombadori, Edda Boccia, Elena Huong Tran, et al.
Targeted Oncology
|
September 24, 2022
Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study
Michelino De Laurentiis, Roberta Caputo, Manuelita Mazza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2008
Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha
Paolo Pedrazzoli, Antonio Farris, Salvatore Del Prete, et al.
Journal of the National Cancer Institute
|
February 5, 2025
Prognostic implications of risk definitions from the monarchE and NATALEE trials
Luca Arecco, Eva Blondeaux, Marco Bruzzone, et al.
Critical Reviews in Oncology/Hematology
|
July 8, 2024
Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2
Alessandra Fabi, Laura Cortesi, Simona Duranti, et al.
Clinical Breast Cancer
|
June 18, 2019
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer
Stefania Gori, Fabio Puglisi, Stefano Moroso, et al.
Journal of Personalized Medicine
|
April 3, 2021
Development of a Digital Research Assistant for the Management of Patients' Enrollment in Oncology Clinical Trials within a Research Hospital
Alfredo Cesario, Irene Simone, Ida Paris, et al.
Cancers
|
March 10, 2022
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience
Alba Di Leone, Antonio Franco, Daniela Andreina Terribile, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 265) with videos related to
Sort By:
Page
of 27
Cancers
|
January 22, 2021
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives
Michela Roberto, Antonio Astone, Andrea Botticelli, et al.
Therapeutic Advances in Medical Oncology
|
March 20, 2023
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
Giovanna Garufi, Luisa Carbognin, Isabella Sperduti, et al.
La Radiologia Medica
|
March 21, 2025
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria
Charlotte Trombadori, Edda Boccia, Elena Huong Tran, et al.
Targeted Oncology
|
September 24, 2022
Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study
Michelino De Laurentiis, Roberta Caputo, Manuelita Mazza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2008
Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha
Paolo Pedrazzoli, Antonio Farris, Salvatore Del Prete, et al.
Journal of the National Cancer Institute
|
February 5, 2025
Prognostic implications of risk definitions from the monarchE and NATALEE trials
Luca Arecco, Eva Blondeaux, Marco Bruzzone, et al.
Critical Reviews in Oncology/Hematology
|
July 8, 2024
Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2
Alessandra Fabi, Laura Cortesi, Simona Duranti, et al.
Clinical Breast Cancer
|
June 18, 2019
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer
Stefania Gori, Fabio Puglisi, Stefano Moroso, et al.
Journal of Personalized Medicine
|
April 3, 2021
Development of a Digital Research Assistant for the Management of Patients' Enrollment in Oncology Clinical Trials within a Research Hospital
Alfredo Cesario, Irene Simone, Ida Paris, et al.
Cancers
|
March 10, 2022
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience
Alba Di Leone, Antonio Franco, Daniela Andreina Terribile, et al.
Page
of 27